 |
|
|
|
|
|
Showing Treatment 1 to 25 of 347 Next 25 |
|
Location |
|
Last Updated |
|
|
|
Details |
|
Efficacy and Safety of AP 12009 (trabedersen) in Patients With Recurrent or Refractory Anaplastic Astrocytoma (SAPPHIRE) |
|
Gießen, Germany |
|
08/31/2010 |
|
|
|
|
|
Details |
|
Efficacy and Safety of AP 12009 (trabedersen) in Patients With Recurrent or Refractory Anaplastic Astrocytoma (SAPPHIRE) |
|
Montreal, Canada |
|
08/31/2010 |
|
|
|
Details |
|
Efficacy and Safety of AP 12009 (trabedersen) in Patients With Recurrent or Refractory Anaplastic Astrocytoma (SAPPHIRE) |
|
Hamburg, Germany |
|
08/31/2010 |
|
|
|
|
|
Details |
|
Efficacy and Safety of AP 12009 (trabedersen) in Patients With Recurrent or Refractory Anaplastic Astrocytoma (SAPPHIRE) |
|
Graz, Austria |
|
08/31/2010 |
|
|
|
Details |
|
Efficacy and Safety of AP 12009 (trabedersen) in Patients With Recurrent or Refractory Anaplastic Astrocytoma (SAPPHIRE) |
|
Innsbruck, Austria |
|
08/31/2010 |
|
|
|
|
|
Details |
|
Efficacy and Safety of AP 12009 (trabedersen) in Patients With Recurrent or Refractory Anaplastic Astrocytoma (SAPPHIRE) |
|
Wien, Austria |
|
08/31/2010 |
|
|
|
Details |
|
Efficacy and Safety of AP 12009 (trabedersen) in Patients With Recurrent or Refractory Anaplastic Astrocytoma (SAPPHIRE) |
|
Marseille, France |
|
08/31/2010 |
|
|
|
|
|
Details |
|
Efficacy and Safety of AP 12009 (trabedersen) in Patients With Recurrent or Refractory Anaplastic Astrocytoma (SAPPHIRE) |
|
Nancy, France |
|
08/31/2010 |
|
|
|
Details |
|
Efficacy and Safety of AP 12009 (trabedersen) in Patients With Recurrent or Refractory Anaplastic Astrocytoma (SAPPHIRE) |
|
Rouen, France |
|
08/31/2010 |
|
|
|
|
|
Details |
|
Efficacy and Safety of AP 12009 (trabedersen) in Patients With Recurrent or Refractory Anaplastic Astrocytoma (SAPPHIRE) |
|
Bonn, Germany |
|
08/31/2010 |
|
|
|
Details |
|
Efficacy and Safety of AP 12009 (trabedersen) in Patients With Recurrent or Refractory Anaplastic Astrocytoma (SAPPHIRE) |
|
Freiburg, Germany |
|
08/31/2010 |
|
|
|
|
|
Details |
|
Efficacy and Safety of AP 12009 (trabedersen) in Patients With Recurrent or Refractory Anaplastic Astrocytoma (SAPPHIRE) |
|
Günzburg, Germany |
|
08/31/2010 |
|
|
|
Details |
|
Efficacy and Safety of AP 12009 (trabedersen) in Patients With Recurrent or Refractory Anaplastic Astrocytoma (SAPPHIRE) |
|
Hannover, Germany |
|
08/31/2010 |
|
|
|
|
|
Details |
|
Efficacy and Safety of AP 12009 (trabedersen) in Patients With Recurrent or Refractory Anaplastic Astrocytoma (SAPPHIRE) |
|
Heidelberg, Germany |
|
08/31/2010 |
|
|
|
Details |
|
Efficacy and Safety of AP 12009 (trabedersen) in Patients With Recurrent or Refractory Anaplastic Astrocytoma (SAPPHIRE) |
|
Leipzig, Germany |
|
08/31/2010 |
|
|
|
|
|
Details |
|
Efficacy and Safety of AP 12009 (trabedersen) in Patients With Recurrent or Refractory Anaplastic Astrocytoma (SAPPHIRE) |
|
Magdeburg, Germany |
|
08/31/2010 |
|
|
|
Details |
|
Efficacy and Safety of AP 12009 (trabedersen) in Patients With Recurrent or Refractory Anaplastic Astrocytoma (SAPPHIRE) |
|
Münster, Germany |
|
08/31/2010 |
|
|
|
|
|
Details |
|
Efficacy and Safety of AP 12009 (trabedersen) in Patients With Recurrent or Refractory Anaplastic Astrocytoma (SAPPHIRE) |
|
Regensburg, Germany |
|
08/31/2010 |
|
|
|
Details |
|
Efficacy and Safety of AP 12009 (trabedersen) in Patients With Recurrent or Refractory Anaplastic Astrocytoma (SAPPHIRE) |
|
Bangalore, India |
|
08/31/2010 |
|
|
|
|
|
Details |
|
Efficacy and Safety of AP 12009 (trabedersen) in Patients With Recurrent or Refractory Anaplastic Astrocytoma (SAPPHIRE) |
|
Bangalore, India |
|
08/31/2010 |
|
|
|
Details |
|
Efficacy and Safety of AP 12009 (trabedersen) in Patients With Recurrent or Refractory Anaplastic Astrocytoma (SAPPHIRE) |
|
Bangalore, India |
|
08/31/2010 |
|
|
|
|
|
Details |
|
Efficacy and Safety of AP 12009 (trabedersen) in Patients With Recurrent or Refractory Anaplastic Astrocytoma (SAPPHIRE) |
|
Chennai, India |
|
08/31/2010 |
|
|
|
Details |
|
Efficacy and Safety of AP 12009 (trabedersen) in Patients With Recurrent or Refractory Anaplastic Astrocytoma (SAPPHIRE) |
|
Cochin, India |
|
08/31/2010 |
|
|
|
|
|
Details |
|
Efficacy and Safety of AP 12009 (trabedersen) in Patients With Recurrent or Refractory Anaplastic Astrocytoma (SAPPHIRE) |
|
Hyderabaad, India |
|
08/31/2010 |
|
|
|
Details |
|
Efficacy and Safety of AP 12009 (trabedersen) in Patients With Recurrent or Refractory Anaplastic Astrocytoma (SAPPHIRE) |
|
Kolkata, India |
|
08/31/2010 |
|
|
|
|
|
